This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SnoreRx® Offers Painless Cure For Snoring

LAGUNA HILLS, Calif., Nov. 23, 2012 /PRNewswire/ -- Larry Risser, Vice President, Apnea Sciences Corporation, reports that although SnoreRx® came to market just ten months ago, sales have literally exploded. "The market has certainly confirmed that people want and need the painless cure for snoring.  We now see a domino effect taking place whereby one woman tells her friends, who tell their friends, who tell their friends, and so on.  These women have literally been our sales ambassadors," according to Mr. Risser, fueling incredible growth. "The grateful customer calls are very gratifying when someone tells us that we have saved their relationship, or that intimacy has returned to their marriage."

SnoreRx's® Thermal-Fit design takes a custom impression of the person's teeth combined with its patented Micro-Fit design allows precise calibration to each person's mouth resulting in superior clinical effectiveness and comfort. People have discovered that SnoreRx®, really does cure their snoring and is easy to wear. SnoreRx's® low cost removes any barrier to consumer purchasing.  

Risser said, "We are now receiving international interest from resort hotels and casinos, cruise lines, duty free shops and specialty stores all seeking to sell SnoreRx®."  To manage the rapidly growing international demand, Apnea Sciences has moved aggressively to enter into master distribution contracts with:
  • Russia  - Termo-Kont MK Ltd.
  • Europe - International Healthcare, Inc.
  • AS Asia Company, Ltd.
  • United Arab Emerites - Gaspar Holdings Company, Ltd.

Jimmy Fallon, Co Founder, said, "As we look forward to 2013 we see incredible growth in worldwide demand for SnoreRx® because both husband and wife deserve a good night's rest." The Cleveland Clinic estimates that over 75 million Americans snore, and worldwide demand is certainly ten times greater.  Yes, the future growth for SnoreRx's® patented cure for snoring appears limitless!

Contact: Jim Fallon949-348-2675


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs